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Aspergillus fumigatus	is	a	model	fungal	pathogen	and	a	common	cause	of	infection	in	individuals	with	the	pri-
mary	immunodeficiency	chronic	granulomatous	disease	(CGD).	Although	primarily	considered	a	deficiency	
of	innate	immunity,	CGD	is	also	linked	to	dysfunctional	T	cell	reactivity.	Both	CD4+	and	CD8+	T	cells	mediate	
vaccine-induced	protection	from	experimental	aspergillosis,	but	the	molecular	mechanisms	leading	to	the	gen-
eration	of	protective	immunity	and	whether	these	mechanisms	are	dysregulated	in	individuals	with	CGD	have	
not	been	determined.	Here,	we	show	that	activation	of	either	T	cell	subset	in	a	mouse	model	of	CGD	is	contin-
gent	upon	the	nature	of	the	fungal	vaccine,	the	involvement	of	distinct	innate	receptor	signaling	pathways,	and	
the	mode	of	antigen	routing	and	presentation	in	DCs.	Aspergillus	conidia	activated	CD8+	T	cells	upon	sorting	
to	the	Rab14+	endosomal	compartment	required	for	alternative	MHC	class	I	presentation.	Cross-priming	of	
CD8+	T	cells	failed	to	occur	in	mice	with	CGD	due	to	defective	DC	endosomal	alkalinization	and	autophagy.	
However,	long-lasting	antifungal	protection	and	disease	control	were	successfully	achieved	upon	vaccination	
with	purified	fungal	antigens	that	activated	CD4+	T	cells	through	the	endosome/lysosome	pathway.	Our	study	
thus	indicates	that	distinct	intracellular	pathways	are	exploited	for	the	priming	of	CD4+	and	CD8+	T	cells	to	
A. fumigatus	and	suggests	that	CD4+	T	cell	vaccination	may	be	able	to	overcome	defective	antifungal	CD8+	T	cell	
memory	in	individuals	with	CGD.
Introduction
Aspergillus fumigatus is a model fungal pathogen and a common 
cause of severe infections and diseases. Humans inhale hundreds 
of conidia per day without adverse consequences (1), except for a 
small minority of persons who may develop life-threatening forms 
of aspergillosis. Despite the lack of evidence for susceptibility to 
aspergillosis in patients with congenital absence of T cells (2), 
CD4+ and CD8+ T cells are present in the human T cell repertoire 
to the fungus (3–5), and adoptive transfer of A. fumigatus–specific 
CD4+ T cells conferred protection against invasive aspergillosis (5, 
6). As with other fungi (7–10), antigen-specific CD4+ and CD8+ 
T cell memory to A. fumigatus has been demonstrated in experi-
mental aspergillosis (11). However, the molecular mechanisms 
leading to T cell memory are largely unknown.
It is becoming increasingly apparent that the optimization of 
vaccines depends crucially on fuller understanding of the mecha-
nisms and processes that give rise to immunological memory, 
including adjuvant formulation, innate immunity, and antigen 
presentation by DCs (12). Although DCs process and present anti-
gens efficiently irrespective of the route of antigen capture (13), the 
nature of the protein, perhaps through its mechanism of uptake, is 
important in determining the access to the endocytic pathway, the 
intersection of which with MHC-containing subcellular compart-
ments determines crucially the course and types of antigen pre-
sentation (14). Owing to the ability of DCs to initiate and regulate 
fungus-specific adaptive immune responses and to improve fungal 
vaccines (15), defining fungal uptake and presentation by DCs may 
help in the understanding of immunological memory to Aspergil-
lus and its dysregulation in diseases. The above consideration may 
be particularly relevant in chronic granulomatous disease (CGD), 
a primary immunodeficiency caused by the inherited disorder of 
the phagocyte NADPH oxidase (NOX2) (16, 17) that is associated 
with infections by Aspergillus spp (18). Although it is considered 
an “innate immunity” disease, increasing evidence links CGD 
with a higher risk of developing autoimmunity (19). It has indeed 
been shown that NOX2 activity participates in the regulation of 
the phagosomal and endosomal pH in DCs and is required for 
efficient antigen cross-presentation (20, 21). Thus, the defect in 
antigen presentation described in patients with CGD may reveal 
an unsuspected role for T cell and adaptive immunity in the patho-
genesis of aspergillosis in this immunodeficiency.
In this study we have assessed the antigen presentation path-
ways in DCs underlying the generation of CD4+ or CD8+ T cell 
responses to the fungus in NADPH deficiency. The activation of 
either T cell subset was contingent upon the nature of the fun-
gal vaccine, the involvement of distinct innate receptor signaling 
pathways, and the mode of antigen routing and presentation in 
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DCs. MHC class I–restricted CD8+ memory T cells failed to be 
generated in NADPH deficiency, due to defective DC endosomal 
alkalinization and autophagy. However, long-lasting antifungal 
protection could be successfully achieved upon vaccination with 
purified fungal antigens activating CD4+ T cells through the 
endosome/lysosome pathway. Thus, distinct intracellular path-
ways are exploited for CD4+ or CD8+ T cell priming to the fungus 
such that CD4+ T cell vaccination may overcome defective CD8+ 
T cell memory to A. fumigatus in CGD.
Results
CD8+ T cell vaccination against A. fumigatus is defective in p47phox–/– 
mice. We used well-established experimental models of vaccine-
induced resistance against aspergillosis (22) to assess the ability 
of p47phox–/– mice (a model of CGD) to develop memory responses 
to A. fumigatus. Mice were intranasally preexposed to sublethal 
live A. fumigatus conidia or the protective (22) recombinant fun-
gal aspartic protease (Pep1p) with CpG as adjuvant, and assessed 
for resistance to subsequent infection in terms of survival, fungal 
growth, and lung histopathology, as well as pattern of cytokine 
production. In contrast to C57BL/6 mice, p47phox–/– mice failed 
to develop vaccine-induced resistance to conidia, as revealed by 
the inability to survive the infection (Figure 1A), restrict fungal 
growth (Figure 1, B and C), control lung inflammation (Figure 
1C), and activate antigen-specific T cells for IFN-γ and IL-10 
production (Figure 1D). Failure to acquire vaccine-induced resis-
tance was also observed upon subcutaneous exposure to viable 
conidia (Figure 1, A–D) or intranasal exposure to inactivated 
conidia (Supplemental Figure 1; supplemental material available 
online with this article; doi:10.1172/JCI60862DS1); these find-
ings point to a generalized T cell defect in response to conidia 
in p47phox–/– mice that was not secondary to the failure to clear 
Figure 1
p47phox–/–  mice fail to develop vaccine-induced resistance to A. fumigatus conidia. Mice (6/group) received A. fumigatus conidia i.n. or s.c 14 
days before reinfection with Aspergillus conidia i.n. Pep1p was given i.n. with CpG 14, 7, and 3 days before reinfection. Mice were given cyclo-
phosphamide a day before reinfection. Vaccine-induced resistance was assessed in terms of (A) survival (%); (B) fungal growth (log10 CFU ± 
SEM); (C) lung histology (PAS staining and Gomori staining in the insets, visualized, respectively, with an original magnification of ×200 and 
×1,000); and (D) cytokine production (ELISA) by purified lung T cells cultured in vitro with conidia- or Pep1p-pulsed DCs from the corresponding 
naive mice. In C, values represent percentages of polymorphonuclear (PMN) or mononuclear (MNC) cells in the BAL. Assays were done at 3 
days after infection. Data are pooled or representative (histology) of 3 independent experiments.*P < 0.05, **P < 0.01, ***P < 0.001, vaccinated 
versus unvaccinated (None) mice. Scale bars: 200 μm.
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the primary infection in the lung. Surprisingly, and similar to 
C57BL/6 mice, they developed full resistance upon Pep1p vac-
cination, which was associated with IFN-γ/IL-10 production 
by antigen-specific T cells (Figures 1, A–D). Pep1p vaccination 
was also observed with Pep1p coated on microparticles of the 
approximate size of conidia (Supplemental Figure 2), a find-
ing that discloses the relative contribution of CpG to vaccina-
tion. Indeed, despite the ability of CpG alone to slightly increase 
resistance to reinfection in p47phox–/– mice (Supplemental Figure 
3, A and B), this increased resistance was not as long-lasting as 
that induced by Pep1p, and was no longer apparent at 60 days 
after vaccination (Supplemental Figure 3, C and D). Similar to 
C57BL/6 mice (22), p47phox–/– mice also developed full resistance 
against two other protective Aspergillus recombinant antigens, the 
cell wall–associated transglycosidases (Gel1p and Crf1p), and not 
to the non-protective metalloprotease (Mep1p) (Supplemental 
Figure 4). Thus, the ability to respond to purified fungal antigens 
is fully retained in CGD mice, irrespective of the protease activity 
of the fungal antigen.
Murine studies have shown that both CD8+ and CD4+ T cells 
mediate memory responses to fungi via the production of effec-
tor cytokines, such as IFN-γ, and, in the case of CD8+ T cells, 
through cytotoxic activity against fungus-laden cells (7–11). The 
requirement for IFN-γ in vaccine-mediated resistance was con-
firmed by vaccination of Ifng–/– or Il17ra–/– mice with Aspergillus 
conidia or Pep1p. Both vaccines retained the vaccinating poten-
tial in Il17ra–/– mice, albeit to a lesser degree for conidia, as com-
pared with wild-type mice, but both failed to induce resistance in 
Ifng–/– mice (Supplemental Figure 5, A–C). Increased conidiocidal 
activity (Supplemental Figure 5D), more than induction of pro-
tective defensins (Supplemental Figure 5E), was associated with 
vaccine-induced resistance. Thus, as in humans (23), Th1, and to 
a lesser extent Th17, cells contribute to vaccine-induced resistance 
in murine aspergillosis.
In terms of CD8+ or CD4+ T cell activation, conidia-induced 
resistance was abrogated in C57BL/6 mice upon blocking of class I 
antigens or CD8 (Figure 2A) and in CD8-deficient mice (Supple-
mental Figure 6), whereas Pep1p-induced resistance was abro-
gated in both types of mice upon blocking of class II antigens 
or CD4 (Figure 2B) and in CD4-deficient mice (Supplemental 
Figure 6). Actually, CD4+, more than CD8+, T cells were detected 
in the lungs of CGD mice in infection (Figure 2C), and CD4+ 
T cells from these mice responded to Pep1p stimulation in vitro 
in terms of proliferation (Figure 2D) and Ifng gene expression 
(Figure 2E) to the same or even a greater extent than C57BL/6 
mice. In contrast, CD8+ T cells were activated in response to 
conidia in C57BL/6 mice only, as indicated by proliferation, Ifng 
and Prf1 expression (Figure 2, D–F), and cytotoxic activity against 
fungus-pulsed DCs (Figure 2G) or the fungus itself (Figure 2H). 
Consistent with the ability of antigens delivered in particulate 
form to induce robust CD8+ T cell activation (24, 25), CD8+ 
T cells were also induced by vaccination with Pep1p coated on 
microparticles (Supplemental Figure 2). Thus, despite the abil-
ity of CpG to prime CD8+ T cell immunity to “split” vaccines 
(26), soluble fungal antigens did not elicit class I MHC–restricted 
CD8+ T cell responses, unless delivered in particulate form. Cor-
roborating these findings, phenotypic and functional analysis of 
ex vivo cells revealed that CD4+ T cells from Pep1p-vaccinated 
mice, both wild-type and CGD, and CD8+ T cells from conidia-
vaccinated wild-type mice were CD44hiCD62LloCD45RBloCD25lo, 
consistent with an effector memory phenotype (Figure 2I), and 
stained positive for IFN-γ and IL-10 (Figure 2J). Because p47phox–/– 
mice did not overtly demonstrate an increased susceptibility to 
MCMV infection (Supplemental Figure 7), MHC class I–restrict-
ed CD8+ T cell activation in response to conidia was selectively 
defective, whereas MHC class II–restricted CD4+ T cell responses 
to soluble fungal antigens was apparently facilitated in these 
mice. In fact, consistent with published findings (27), a robust 
Aspergillus-specific humoral response was observed in Pep1p-vac-
cinated p47phox–/– mice (data not shown).
CD4+ or CD8+ T cell vaccination requires distinct TLR signaling. TLR 
signaling triggers a variety of responses that direct and enhance 
antigen presentation (28, 29). Lower levels of MHC class II anti-
gen presentation have indeed been observed in the absence of 
myeloid differentiation primary response gene 88 (MyD88) 
(28) and reduced cross-presentation in the absence of TIR 
domain–containing adapter-inducing interferon–β (TRIF) (30). 
To assess the contribution of the MyD88 and TRIF pathways 
and upstream TLRs in the generation of vaccine-induced resis-
tance, we assessed the vaccinating potential of conidia or Pep1p 
in Myd88–/–, Trif–/–, selected TLR-deficient, or Dectin-1–deficient 
mice. We found that the vaccinating capacity of live conidia was 
lost in Tlr3–/– and Trif–/– mice, whereas the vaccinating capacity 
of Pep1p was lost in Tlr6–/– and Myd88–/– mice (Figure 3, A and 
B), and this was paralleled by a failure to induce the proliferation 
of CD8+ T cells by conidia in Trif–/– mice and of CD4+ T cells by 
Pep1p in Myd88–/– mice (Figure 3C). The vaccinating potential 
of the two other protective fungal antigens (Crf1p and Gel1p) 
was also dependent on MyD88 and Dectin-1/TLR2 (Crf1p) or 
TLR4/TLR6 (Gel1p) (Figure 3, A and B). We concluded that the 
Figure 2
p47phox–/– mice fail to develop MHC class I–restricted CD8+ T cell 
responses to Aspergillus conidia. Mice (6/group) received conidia or 
Pep1p plus CpG as described for Figure 1 and were concomitantly 
treated with the indicated antibodies or an isotype-matched control 
antibody (None). Fungal growth (log10 CFU ± SEM) in conidia-vac-
cinated (A) or Pep1p-vaccinated (B) mice at 3 days after reinfec-
tion. Control (Ct), infected, unvaccinated mice. Pooled data from 3 
experiments are shown. (C) Lung immunohistochemistry 3 days after 
reinfection. Cell surface markers were Alexa Fluor 488–anti-CD4 and 
Alexa Fluor 647–anti-CD8 antibody. Cell nuclei were stained with DAPI 
(blue). Representative pictures (of 3 experiments) were taken with an 
original magnification of ×200. (D) Proliferation of CD4+ and CD8+ 
T cells purified from lungs 1 week after a primary i.n. infection. DNA 
synthesis was measured by 3H-thymidine uptake after 72 hours cocul-
ture with conidia- or Pep1p-pulsed DCs from the corresponding naive 
mice. Ct, T cells alone. Relative expression of (E) Ifng and (F) Prf1 
by RT-PCR in CD4+ and CD8+ T cells exposed to conidia- or Pep1p-
pulsed DCs for 24 hours. (G) Cytolytic activity of CD8+ T cells, obtained 
as in D, against conidia-pulsed DCs at different E/T ratios. Shown is 
the percentage of specific cytotoxic activity determined by a standard 
4-hour 51Cr-release assay. (H) Conidiocidal activity of culture super-
natants from CD8+ T cells exposed as in D (visualized with an original 
magnification of ×400). Activation/memory marker expression (I) and 
intracellular cytokine staining (J) by lung CD8+ and CD4+ T cells puri-
fied from conidia- or Pep1p-vaccinated mice, respectively, 3 days after 
reinfection. Histograms were generated from pooled samples of 6 mice/
group. Representative histograms from a single experiment are shown. 
Values are the percentages of positive cells. *P < 0.05, **P < 0.01, 
***P < 0.001 treated versus untreated mice (A and B) and pulsed DC–
stimulated versus unstimulated cells (None) (D–G).
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Figure 3
CD4+ or CD8+ T cell vaccination to A. fumigatus 
requires distinct TLR signaling. Dectin-1, TLR-, 
MyD88-, or TRIF-deficient mice were admin-
istered A. fumigatus conidia or the protective 
recombinant fungal antigens (Pep1p, Gel1p, or 
Crf1p) plus CpG and assessed for resistance 
to reinfection in terms of (A) survival (%), (B) 
fungal growth (log10 CFU ± SEM), and (C) pro-
liferation of CD4+ or CD8+ T cells, purified from 
Pep1p- or conidia-vaccinated mice, respective-
ly, at 3 days after infection, and cultured in vitro 
with conidia- or Pep1p-pulsed DCs from the 
corresponding naive mice. DNA synthesis was 
measured by 3H-thymidine uptake after 72 hours 
coculture. *P < 0.05, **P < 0.01, ***P < 0.001, 
vaccinated versus unvaccinated (None) mice. 
ND, not done. Data are representative of 3 
experiments.
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TLR3/TRIF pathway is required for CD8-mediated resistance to 
live conidia, whereas the MyD88 pathway essentially contributes 
to CD4-mediated resistance to purified fungal antigens with the 
participation of different TLRs. As both TLR3 expression (Sup-
plemental Figure 8A) and responsiveness to TLR3 (Supplemen-
tal Figure 8B) were preserved in CGD mice, mechanisms other 
than TLR expression are apparently responsible for defective 
CD8+ T cell memory in CGD.
CD4+ and CD8+ T cells are activated through distinct intracellular 
antigen presentation pathways. In the classical antigen presentation 
pathways, endogenous antigens are processed by the protea-
some and loaded on MHC class I molecules in the ER to activate 
cytotoxic CD8+ T cells. In contrast, exogenous antigens taken 
up by endocytosis or phagocytosis are degraded and loaded on 
MHC class II in lysosome-derived organelles for CD4+ T cell acti-
vation (31, 32). However, evidence for alternative cross-presen-
tation of exogenous antigens on MHC class I for CD8+ T cells 
has also emerged, such as alternate vacuolar MHC class I pro-
cessing (31), a pathway for particulate antigens with no known 
mechanism for cytosolic penetration (24). To define which of 
the above pathways were activated in CD4+ or CD8+ T cell vac-
cination, we assessed CD8+ or CD4+ T cell priming by lung DCs 
pulsed with conidia or Pep1p, respectively, in conditions of effi-
cient (chloroquine) or inhibited (diphenyleneiodonium [DPI]) 
endosomal alkalinization, as alkalinization of the phagosomal 
and endosomal pH in DCs prevented the activation of lysosomal 
proteases, thus rescuing internalized particulate antigens from 
rapid degradation and allowing their loading onto MHC class I 
(20, 21, 32). In addition, we used brefeldin A (33) or lactacystin 
(34) to inhibit the alternate vacuolar or the classical cytosolic 
MHC class I pathway, respectively, and 3-methyladenine 
(3-MA) or rapamycin to inhibit or promote, respectively, (35, 36), 
autophagy, a highly conserved cellular process of self-degrada-
tion, involved in MHC class I and class II antigen presentation as 
well as in cross-presentation (37–39). We found that CD8+ T cell 
priming (proliferation and Ifng gene expression) was inhibited 
by DPI, lactacystin, and 3-MA; was dependent on brefeldin A; 
and was promoted by chloroquine and rapamycin (Figure 4A). 
Experiments with p47phox–/– DCs showed that treatment with 
chloroquine, but not rapamycin, restored CD8+ T cell activation 
(Figure 4A). These findings indicate that handling of conidia 
by DCs for efficient CD8+ T cell activation occurs through the 
cytosolic and vacuolar MHC class I pathways and is facilitated 
by endosomal alkalinization and autophagy. In contrast, chlo-
roquine but not 3-MA or rapamycin inhibited Pep1p-induced 
CD4+ T cell activation, indicating a requirement for endosomal 
acidification but not autophagy in class II–restricted CD4+ T cell 
activation (Figure 4B). Thus, CD4+ and CD8+ T cells appeared 
to be activated through distinct intracellular antigen presenta-
tion pathways. While the MHC class II pathway leading to CD4+ 
T cell activation operated normally in CGD, the MHC class I 
pathway to phagocytosed conidia was instead impaired, demon-
strating that our understanding of antigen handling based on 
model antigens extends to pathogens (21).
Figure 4
CD4+ and CD8+ T cells are activated through distinct intracellular antigen presentation pathways. CD8+ or CD4+ T cells were purified from 
lungs of C57BL/6 or p47phox–/– mice a week after the intranasal infection and exposed to conidia-pulsed (A) or Pep1p-pulsed (B) DCs purified 
from lungs of the corresponding naive mice. Prior to the 2-hour pulsing with conidia or Pep1p, DCs were exposed to the indicated antigen 
presentation pathway inhibitors for 120 minutes. (C) CD8+ T cells, purified as in A, were exposed to DCs and/or intact or apoptotic (Apo) 
alveolar macrophages (AM), purified from lungs of the corresponding naive mice. AMs were pulsed to live conidia before the induction of 
apoptosis with LPS plus ATP. Cells were assessed for proliferation and Ifng expression by RT-PCR, 72 hours after the coculture. DNA syn-
thesis was measured by 3H-thymidine uptake. Data are from 4 independent experiments.*P < 0.05, **P < 0.01, inhibitors versus no inhibitors; 
and DC-exposed versus T cells alone (Ct).
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Given the ability of macrophages to cross-present phagocytosed 
antigens (40) and to promote cross-presentation in DCs via trans-
fer of fungal antigens upon apoptosis (41), we assessed both func-
tions in lung macrophages from wild-type and CGD mice. While 
neither CD8+ T cell proliferation nor Ifng gene expression was 
observed with macrophages from either type of mice (Figure 4C), 
DCs efficiently activated CD8+ T cells upon coculture with apop-
totic macrophages that had phagocytosed live conidia but failed 
to do so with non-apoptotic macrophages (Figure 4C). Because 
A. fumigatus conidia inhibit apoptosis of alveolar macrophages via 
caspase-3 inhibition (42) and we failed to detect macrophage apop-
tosis after phagocytosis of conidia (data not shown), it is unlikely 
that DC ingestion of apoptotic macrophages actually contributes 
to cross-presentation in vivo.
Distinct intracellular routing of conidia and soluble fungal antigens in 
DCs. To find out whether distinct intracellular routings for live 
conidia and soluble antigens in DCs could explain the activation 
of either T cell type, we followed the intracellular location of GFP-
conidia or Alexa Fluor 488–labeled Pep1p by determining the co-
localization and quantifying the degree of overlap (Supplemental 
Table 1) with members of the Rab small GTPase family, known to 
be specifically localized to different intracellular organelles and 
to regulate endocytic traffic (43). We used Rab5 for its association 
with the clathrin-dependent endocytic pathway and early endo-
somes (44); Rab7 to detect early-to-late endosomal maturation 
(45); Rab9 because it stimulates late endosome to trans-Golgi net-
work (TGN), a major secretory pathway (46); and Rab14 because 
it reduces routing of antigens from early endosomes to the acidic 
lysosomal environment, thus limiting antigen degradation and 
favoring cross-presentation in DCs (47). We also assessed co-local-
ization with the mannose receptor (MR) that targets the mildly 
acidic stable early endosomal compartment where presentation on 
MHC I molecules and Th1 polarization occur (32, 48); and with 
lysosomal-associated membrane protein 1 (Lamp1), a transmem-
brane glycoprotein that is localized primarily in late endosomes 
and lysosomes (43). We found that Aspergillus conidia colocalized 
with MR, Rab5, and Rab14 at 15 minutes after phagocytosis (Fig-
ure 5A), being evident as early as after 5 minutes (data not shown). 
Conidia were also found to be associated with Rab7, Rab9, and 
Lamp1 at 45 minutes (Figure 5A) and, in the case of Lamp1, also 
at 120 minutes (data not shown). Thus, phagocytosed conidia are 
routed to both the late endosome/lysosome and the Rab14+ com-
partments. Of great interest, the routing of conidia to the Rab14+ 
compartment (Figure 5B) but not to Lamp1 (data not shown) was 
unaffected by chloroquine but was greatly impaired upon block-
ing of autophagy with 3-MA (Figure 5B), a finding suggesting 
the participation of autophagy in the escape of conidia from the 
endosome/lysosome compartment to the Rab14+ compartment. 
At variance with conidia, the Alexa Fluor 488–labeled Pep1p colo-
calized sequentially with MR, Rab5, Rab7, Rab9, and Lamp1, with 
minimal or no co-localization with Rab14 (Figure 5A). Thus, the 
routing to the late endosome/lysosome compartment is appar-
ently required for adequate processing and presentation of soluble 
fungal antigens for CD4+ T cell activation. This requirement was 
further confirmed by analyzing the co-localization of the non-pro-
tective fungal antigen Mep1p. Similar to Pep1p, Mep1p colocal-
ized with MR and Rab5 but not Rab14 (Supplemental Figure 9). 
At variance with Pep1p, it rapidly (at 15 minutes) and maximally 
(at 45 minutes, data not shown) colocalized with Rab9 and weakly 
with Lamp1 (Supplemental Figure 9), a finding suggesting that 
transporting antigens from late endosomes to the TGN prevents 
adequate processing and presentation of antigens for CD4+ T 
cell activation. These results indicate a different routing for live 
conidia and soluble fungal antigens in DCs. Like soluble fungal 
antigens, phagocytosed conidia are routed to the endosome/lyso-
some compartment, from where conidia are diverted to the Rab14+ 
compartment through autophagy.
The intracellular routing of conidia in DCs is altered in NOX2 defi-
ciency. We next assessed the routing (co-localization and its quan-
tification, Supplemental Table 1) of GFP-conidia or Alexa Fluor 
488–labeled Pep1p in p47phox–/– DCs. Similar to wild-type DCs, 
Aspergillus conidia colocalized with MR and Rab5 at 15 minutes 
after phagocytosis (Figure 5C) and with Rab7/Rab9/Lamp1at 
45 minutes (Figure 5C). In contrast, co-localization with Rab14 
was observed neither at 15 minutes (Figure 5C) nor at later time 
points (data not shown). Thus, the rerouting of conidia away 
from the lysosomal compartment is defective in the absence of 
NOX2. Similar to what was observed in wild-type DCs, Pep1p 
colocalized sequentially with MR, Rab5, Rab7, Rab9, and Lamp1, 
with minimal or no co-localization with Rab14 (Figure 5C). 
However, chloroquine but not 3-MA greatly promoted the co-
localization of Pep1p with Rab14 (Figure 5D), a finding sug-
gesting that endosomal alkalinization, while rescuing peptides 
from degradation, may favor rerouting of soluble antigens to the 
Rab14+ compartment. These results indicate that live conidia 
failed to be sorted in the Rab14+ compartment in the absence 
of NOX2-dependent autophagy, while endosomal alkalinization 
apparently favors the Rab14+ sorting of soluble fungal antigens. 
Further studies confirmed that CD11bloCD103+ DCs or CD8α+ 
DCs, known to mediate CD8+ T cell cross-priming (49, 50), were 
not defective in the lungs of CGD mice (Supplemental Figure 
10), whereas a population of CD11chiCD11bhi myeloid DCs, 
known to prime CD4+ T cell responses to A. fumigatus (51), was 
expanded in these mice (Figure 6A), as already described (52). 
p47phox–/– DCs phagocytosed conidia in vitro (Figure 6B) and in 
vivo (Figure 6C) and responded to conidia in terms of Il23p19 
expression (Figure 6D) and ERK phosphorylation (Figure 6E) 
but not in terms of Il12p35 and Il10 expression (Figure 6D), a 
finding indicating that handling of conidia is somehow altered 
in NADPH deficiency. Upon Pep1p stimulation, in contrast to 
conidia stimulation, p47phox–/– DCs responded to the same or a 
Figure 5
Distinct intracellular routing of Aspergillus conidia and soluble fun-
gal antigens in DCs and its subversion in the absence of NADPH. 
Immunofluorescence imaging of purified DCs from lungs of C57BL/6 
(A) or p47phox–/– (C) mice after in vitro exposure to GFP-conidia or 
Alexa Fluor 488–Pep1p at 37°C for 2 hours and chasing for 15 and 
45 minutes. (B and D) DCs were preincubated with 5 mM 3-MA or 
5 μg/ml chloroquine for 30 minutes prior to exposure to GFP-conidia or 
to Alexa Fluor 488–Pep1p. Formaldehyde-fixed DCs were incubated 
with primary antibodies against MR, Rab5, Rab7, Rab9, Rab14, and 
Lamp1, followed by secondary anti-rabbit IgG–TRITC antibody. Nuclei 
were counterstained with DAPI. Images were acquired using a fluo-
rescence microscope (BX51) with an original magnification of ×1,000 
and analySIS image processing software. Shown are merged images 
of DCs (a single cell is magnified in the inset visualized with an original 
magnification of ×1,000) pulsed with GFP-conidia or fungal antigens 
(green) and red-stained for each endosomal compartment. Shown are 
representative data from 4 independent experiments. For quantitative 
analysis of co-localization, see Supplemental Table 1.
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greater extent as C57BL/6 DCs (Figure 6, D and E) and, pulsed 
with Pep1p, were fully able to confer vaccine-induced resistance 
in vivo upon adoptive transfer into C57BL/6 mice with aspergil-
losis (Figure 6, F and G). Thus, the intracellular routing for live 
conidia and soluble antigens in DCs is apparently subverted in 
conditions of NADPH deficiency.
Autophagy restores defective cross-presentation of conidia in p47phox–/– 
mice. To assess whether restoring defective autophagy in CGD (53) 
could result in CD8+ T cell–mediated resistance in vivo, we first 
monitored the occurrence of autophagy in response to the fun-
gus and/or fungal antigens. We transiently transfected RAW 264.7 
cells with the EGFP-LC3 plasmid and exposed them to live resting 
Figure 6
CD11b+ p47phox–/– DCs efficiently present fungal antigens. (A and B) Flow cytometry of phagocytosis of live GFP-expressing conidia by lung 
DCs purified from uninfected mice. Values are percentages of positive cells on T and B cell–depleted lung cells. Phagocytosis was quanti-
fied via phase contrast and fluorescence microscopy at ×1,000 magnification (shown are representative microscopy images of 2 independent 
experiments). (C) Mice were infected i.n. with GFP-expressing A. fumigatus conidia, and the numbers of GFP+CD11c+ cells were assessed by 
flow cytometry at 3 days after infection. Values are percentages of positive cells on gated CD11c+ cells. DCs purified from lung of naive mice 
were unpulsed (None) or pulsed with live Aspergillus conidia or Pep1p for (D) 24 hours prior to being assessed for cytokine gene expression by 
RT-PCR and (E) 2 hours before the assessment of pERK44/42 phosphorylation by immunoblot analysis. Shown is a representative Western blot 
of 2 independent experiments and corresponding pixel density ratio normalized against β-tubulin (β-tub). (F and G) Adoptive transfer of C57BL/6 
or p47phox–/– lung DCs pulsed with conidia or Pep1p into C57BL/6 mice. DCs were adoptively transferred by i.p. injection twice, a week apart, 
before the i.n. infection. Fungal growth in the lungs (F, log10 CFU ± SEM, representative of at least 3 independent experiments) and histology (G, 
PAS staining) were determined 3 days after infection. *P < 0.05, **P < 0.01, ***P < 0.001, pulsed versus unpulsed DCs (D) and mice receiving 
or not (None) DCs (F). Scale bars: 200 μm.
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or swollen conidia, to Pep1p, or to known activators of autophagy, 
such as rapamycin and poly(I:C). As with rapamycin and poly(I:C), 
autophagy was induced by swollen but not by resting conidia or 
Pep1p, as indicated by the increased number of cells with punctate 
dots containing EGFP-LC3 as opposed to the diffuse localization 
of the majority of EGFP-LC3 in untreated cells (Figure 7, A and 
B) and the increased ratio of LC3-II to LC3-I by immunoblotting 
(Figure 7C). Autophagy was promoted by resting conidia in the 
presence of poly(I:C) (Figure 7C). Similar results were obtained 
in purified lung DCs from C57BL/6 mice, as revealed by LC3 
immunofluorescence (Figure 7D); mRNA expression levels of the 
autophagy genes LC3a, LC3b, Atg12, and Bcn1 (Figure 7E); and the 
association of Beclin-1, an essential autophagy effector, with TRIF 
(ref. 54 and Figure 7F). Autophagy was not observed in p47phox–/– 
DCs in response to the different stimuli, including rapamycin, 
with the exception of poly(I:C) (Figure 7, D and E), a finding sug-
gesting that mTOR- and NADPH-independent autophagy may 
still be activated in CGD. The induction of autophagy to conidia 
via TLR3 would suggest that the exploitation of TLR3 signaling 
could restore CD8+ T cell memory in CGD mice. This proved to be 
the case, as the administration of conidia with poly(I:C) provided 
resistance to reinfection, a process partially antagonized by block-
ing autophagy (Figure 7G).
Discussion
This study reveals that CD4+ and CD8+ T cell activation in vaccine-
induced resistance to A. fumigatus is contingent upon the nature 
of the fungal vaccine, the involvement of distinct innate recep-
tor signaling pathways, and the mode of antigen routing in DCs 
(Figure 8). Vaccine-induced resistance required IFN-γ, a cytokine 
with effector and immunoregulatory activity against fungi (15), 
and, partially, IL-17RA signaling, a finding pointing to a degree 
of similarity among respiratory fungal pathogens (55). MHC 
class II–restricted CD4+ Th1 cells provided long-lasting antifun-
gal protection and disease control in CGD mice, in which MHC 
class I–restricted CD8+ T cells were not activated due to defective 
autophagy and endosomal alkalinization. Thus, understanding 
memory at basic levels may lead to a vaccination approach in CGD 
patients. As in CGD mice, CD4-dependent but not CD8-depen-
dent memory responses were observed in BALB/c mice (data not 
shown), a finding indicating that the activation of either one of 
antifungal memory response is also contingent upon the host’s 
genetic background.
Activation of CD4+ or CD8+ T cells occurred through distinct 
antigen uptake and presentation pathways. Purified fungal pro-
teins were apparently routed to the endosome/lysosome-depen-
dent MHC class II presentation pathway via MyD88 and the 
involvement of distinct upstream TLRs known to enhance the 
uptake of phagocytosed but also soluble antigens and thus poten-
tiate antigen presentation (28). Further confirming the routing 
toward the MHC class II presentation pathway, treatment with 
nocodazole, which interferes with microtubule-dependent motil-
ity of early endosomes toward maturing endosomes, also blocked 
CD4+ T cell activation to fungal antigens (data not shown). Thus, 
similar to pinocytosed and scavenger receptor endocytosed anti-
gens (14), fungal peptides are targeted toward a common pool of 
endosomes, which mature toward late endosomes and fuse with 
lysosomes, in which peptides for MHC class II–restricted presenta-
tion can be generated. Although primarily expressed on the plas-
ma membrane, TLR2, TLR4, and TLR6 could also recycle through 
early endosomes; target and be activated by (56) the Rab fam-
ily; and control the phagosomal pH (28). Moreover, intracellular 
TLRs, to signal efficiently, need to be proteolytically activated (29). 
Thus, it is likely that TLR trafficking to the diverse organelles may 
explain the involvement of distinct TLRs in the presentation of 
the different fungal antigens. However, precisely how this occurs 
is not known.
En route to lysosomes, purified fungal antigens also targeted to 
the mildly acidic stable early endosomal compartment, where the 
uptake by MR leads to presentation on MHC class I molecules and 
Th1 polarization (32, 48). Mannosylated fungal antigens (both 
N-linked and O-linked mannosylated) exhibited increased immu-
nogenicity compared with proteins lacking mannosylation, were 
taken up by mannose-specific C-type lectin receptors, and colocal-
ized in MHC class II+ compartments (57). We found that deglycosyl-
ated Pep1p no longer acted as a fungal vaccine capable of activating 
CD4-dependent memory to the fungus (data not shown), a finding 
confirming the importance of MR in the rapid internalization and 
concentration of a variety of glycosylated fungal antigens (57).
In contrast to soluble antigens, live conidia or soluble antigens 
delivered in a particulate form activated CD8-dependent memo-
ry through the TLR3/TRIF-dependent pathway. DC subsets are 
known to be capable of exporting internalized antigens from the 
endocytic compartment to the cytosol (58). In this regard, Asper-
gillus-derived antigens may be exported from endocytic compart-
ment to cytosol for conventional MHC class I presentation, as 
CD8+ T cell activation was dependent on proteasomal degrada-
tion. However, the inhibition by brefeldin A, known to inhibit 
the alternate vacuolar MHC class I processing (33), suggests that 
Aspergillus conidia may exploit multiple class I presentation path-
ways for CD8+ T cell activation. Cross-priming itself involves a 
number of distinct mechanisms. How Aspergillus antigens are 
delivered to the cytosol or to the ER-resident, vacuolar-associ-
ated MHC class I molecules is presently unknown. We found that 
autophagy, while dispensable for the transit to the Lamp1 com-
partment, was instead required for diversion from the early endo-
some to the Rab14+ endosomal storage compartment, in which 
yeast interaction with MHC class I molecules has been described 
(47). Thus, like yeasts, conidia likely interact with MHC class I 
molecules in the Rab14+ compartment. Whether this actually 
occurs and the effects of conidia residency in this compartment 
versus the cytosolic compartment for CD8+ T cell responses are 
presently unknown but under investigation.
Primarily associated with MHC class II presentation, by deliv-
ering intracellular material for lysosomal degradation, macroau-
tophagy has been recently shown to present tumor (59, 60) and 
viral antigens (39) on MHC class I, through the classical and vacu-
olar antigen presentation pathways (38). Indeed, by assisting TLRs 
in encountering their cognate ligands, autophagy contributed to 
the CD8+ T cell response to pathogens localized in autophago-
somes containing components of the MHC class I presentation 
pathway (61). Irrespective of the mechanisms through which 
autophagy mediates Aspergillus sorting for MHC class I presenta-
tion, promoting autophagy in vivo provided CD8-dependent anti-
fungal memory. Indeed, TLR3, known to activate DCs for cross-
priming (62), activated both autophagy and CD8+ T cell memory 
in CGD mice. Although the net contribution of autophagy to the 
handling of the fungus and fungal control in infection will likely 
be more complex, our results are the first to our knowledge to 
show a role for autophagy in adaptive immunity to A. fumigatus 
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and suggest that TLR3 adjuvants may optimize vaccination strate-
gies in aspergillosis. Along the same line of reasoning, it will be of 
interest to assess the therapeutic potential of chloroquine, known 
to favor CD8+ T cell activation (63), as well as of inhibitors of cys-
teine and aspartic proteases to define whether excessive epitope 
degradation also contributes to defective cross-presentation of 
fungal antigens in CGD.
Overall, the present study shows that defective cross-presenta-
tion in the absence of NOX2 may contribute to the inability of 
CGD patients to successfully combat A. fumigatus. Because viral 
infections are not common in CGD (18), and CGD mice were 
not more susceptible to MMCV infection (the present study), it 
is likely that mechanisms of cross-presentation of viral versus 
fungal antigens are different, as has been speculated (31). From 
an immunological standpoint, our study highlights how under-
standing molecular and cellular mechanisms of memory at basic 
levels could be exploited to perfect vaccination strategies against 
inflammatory fungal diseases through the appropriate selection of 
fungal antigens and adjuvants and the targeting of DC pathways 
that enhance vaccine potency.
Methods
Mice. Female C57BL/6 mice, 8–10 weeks old, were purchased from Charles 
River. Homozygous p47phox–/–, Dectin-1–/–, Tlr2–/–, Tlr3–/–, Tlr4–/–, Tlr6–/–, Trif–/–, 
Myd88–/–, Ifng–/–, and Il17ra–/– mice on a C57BL/6 background were bred under 
specific pathogen–free conditions at the Animal Facility of Perugia University. 
Cd4–/– and Cd8–/– mice were provided by Annette Oxenius, Institute of Micro-
biology, ETH Zürich, Zurich, Switzerland.
Fungal strains, infections, and treatments. Viable conidia (>95%) from the 
A. fumigatus AF293 strain were obtained by growth on Sabouraud dex-
trose agar (Difco) at room temperature. Swollen conidia were obtained 
as described previously (22). A GFP-expressing strain of A. fumigatus (pro-
vided by M.M. Moore, Department of Biological Sciences, Simon Fraser 
University, Burnaby, British Columbia, Canada) was used to track the fate 
of viable fungi, as GFP expression is rapidly lost following cell death. For 
infection, mice were anesthetized by i.p. injection of 2.5% avertin (Sigma-
Aldrich) before the intranasal instillation of a suspension of 2 × 107 conid-
ia/20 μl saline. Mice were monitored for fungal growth (log10 CFU/organ, 
mean ± SEM), histopathology (PAS and Gomori staining of lung tissue 
sections), and lung immunofluorescence (see below). BAL fluid collection 
and morphometry were done as described previously (22). Histology sec-
tions and cytospin preparations were observed using a BX51 microscope 
(Olympus), and images were captured using a high-resolution DP71 cam-
era (Olympus). Mice were treated with a total of 300 μg anti-CD4 (GK 1.5), 
anti-CD8 (YTS 169), anti–MHC class I-A (34-5-8S), or anti–MHC class II 
(M5/114) mAbs (Bioceros BV) at the time of vaccination. Control mice 
received isotype control rat IgG2a mAb (eBR2a) (eBioscience). Depletion 
of the corresponding T cell subsets with the anti-CD8 or anti-CD4 regimen 
was monitored in each experiment and was consistently between 95% and 
98%, lasting for 3–5 days after treatment (data not shown and Supplemen-
tal Figure 11 for anti–MHC class I mAb). Treatment with anti-CD4 alone, 
but not anti-CD8, anti–MHC class I-A, or anti–MHC class II mAbs alone 
further increased the susceptibility to the infection in cyclophosphamide-
treated mice as compared with control mice (data not shown).
Vaccination models. Two vaccination models were used: one using live or 
inactivated (by autoclaving at 121°C for 30 minutes) A. fumigatus conidia 
or purified fungal antigens given with the immunoadjuvant murine CpG 
oligodeoxynucleotide 1862 or coupled to microparticles; the other using 
antigen-pulsed DCs (22). In the first model, mice received i.n. in 20 μl 
saline one of the following preparations: 2 × 107 live or heat-inactivated 
Aspergillus conidia, 14 days before the infection; 5 μg of the different puri-
fied fungal antigens plus 10 nM CpG-ODN; or 5 μg Pep1p plus 50 μg 
microparticles, administered 14, 7, and 3 days before the infection. Mice 
were immunosuppressed i.p. with 150 mg/kg of cyclophosphamide per day 
before infection. In the adoptive transfer model of antigen-pulsed DCs, 
purified lung CD11c+ DCs were pulsed with viable A. fumigatus conidia (1:1 
cell/fungus ratio) for 2 hours before addition of 2.5 μg/ml amphotericin B 
(Sigma-Aldrich) to prevent A. fumigatus overgrowth or with 5 μg/ml of the 
recombinant fungal antigens Pep1p, Gel1p, and Crh1p produced in Pichia 
pastoris (22). Poly(I:C), 15 μg/20 μl (Sigma-Aldrich), was given with A. fumig-
atus conidia 14 days before the infection. For treatment with siRNA, each 
mouse was lightly anesthetized by inhaled diethyl ether and then given 
intranasal siRNA (10 mg/kg) or equivalent doses of nonspecific control 
siRNA duplex in a volume of 20 μl, in the TransITR-EE Starter Kit (Mirus). 
Intranasal siRNA was given twice together with conidia plus poly(I:C) vac-
cination. Pep1p coupling on 3-μm microparticles based on melamine resin 
(Fluka Analytical, Sigma-Aldrich) was done according to manufacturer’s 
instructions. Stable attachment of Pep1p was monitored by FACS analysis 
showing that more than 85% of microparticles were fluorescent 24 hours 
after coupling with 5 μg Alexa Fluor 488–conjugated Pep1p plus 50 μg 
microparticles. Microparticles coupled with FITC-Pep1p were used to 
monitor effective DC uptake in the lung in vivo, 24 hours after injection.
MCMV infection. Infection with the Smith strain of MCMV, its titration 
in a standard plaque assay on murine embryonic fibroblast cells, and 
determination of cytolytic activity against 51Cr-labeled DCs and frequency 
of IFN-γ– or granzyme B–producing CD8+ T cells (ELISPOT assay) puri-
fied from spleens were done as described previously (64). For histology, 
sections of paraffin-embedded tissues were stained with H&E.
Cell preparation and cultures. CD4+ or CD8+ T cells were purified after 
incubation of non-adherent lung cells with FITC-labeled anti-CD4 
or anti-CD8, followed by anti-FITC MicroBeads (Miltenyi Biotec) as 
described previously (22). T cells were purified by non-adherent lung cells 
Figure 7
Autophagy restores defective cross-presentation of conidia in 
p47phox–/– mice. (A) Fluorescence images of EGFP-LC3 transiently 
transfected RAW 264.7 cells exposed to A. fumigatus swollen (SC) 
or resting (RC) conidia, Pep1p, rapamycin, or poly(I:C) for 4 hours. 
Original magnification, ×1,000. (B) Number of RAW 264.7 cells with 
EGFP-LC3 punctae (mean ± SEM, determined by fluorescence 
microscopy) (n = 2). (C) Cell lysates of EGFP-LC3–transfected RAW 
264.7 cells were probed with anti-GFP antibody followed by IgG-
HRP secondary antibody. Normalization was performed on mouse 
β-tubulin. Quantification was obtained by densitometry image analy-
sis using Image Lab 3.1.1 software. (D) Autophagy on purified lung 
DCs stimulated as above and incubated with anti-LC3 antibody fol-
lowed by PE secondary antibody. Representative images (original 
magnification, ×400) are shown. DAPI was used to detect nuclei. (E) 
Autophagy gene expression by RT-PCR in lung DCs stimulated as 
above. None, unstimulated cells. Data are representative of 2 experi-
ments. (F) Cell lysates from EGFP-LC3–transfected RAW 264.7 cells 
stimulated as in A were subjected to immunoprecipitation with anti-
body to Beclin-1. Immunoprecipitates were probed with polyclonal 
antibody to TRIF. Data are representative of 2 experiments. (G) 
p47phox–/– mice were vaccinated with Aspergillus conidia and poly(I:
C) under the condition of Becn1 inhibition by siRNA administra-
tion. Western blotting of lung cells confirmed that Beclin-1 protein 
decreases upon siBecn1 administration. Fungal growth (log10 CFU 
± SEM) in the lungs was assessed 3 days after infection. Data are 
representative of 2 independent experiments. *P < 0.05, **P < 0.01, 
***P < 0.001, conidia + poly(I:C)–vaccinated versus unvaccinated 
(None) mice and with and without siBecn1.
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with FITC-labeled anti-CD3, followed by anti-FITC MicroBeads. Macro-
phages were isolated from total lung cells after 2-hour plastic adherence 
at 37°C. DCs were isolated with MicroBeads (Miltenyi Biotec) conjugated 
to hamster anti–mouse CD11c mAbs (N418) before magnetic cell sorting 
(22). DCs or macrophages (106 cells/ml) were pulsed with live Aspergil-
lus conidia (5:1 cell/fungus ratio), 5 μg/ml Pep1p, soluble or coated on 
microparticles, for 18 hours before RNA extraction and Western blotting 
or for 2 hours before additional coculture with purified CD4+ or CD8+ 
T cells (2 × 106 cells/ml) for 72 hours for cytokine production, cytokine 
gene expression, and lymphoproliferation. DNA synthesis was measured 
by 3H-thymidine uptake for 6 hours. DCs (2 × 105/ml) and CD8+ T cells 
(2 × 106/ml) were added to Aspergillus-pulsed macrophages (2 × 105/ml) 
for 72 hours. For apoptosis induction, macrophages were treated with 
LPS and ATP, as previously indicated (41), and cell death was confirmed 
by annexin V staining.
Flow cytometry and intracellular staining. All staining reactions were per-
formed at 4°C on cells first incubated with an Fc receptor mAb (2.4G2) to 
reduce nonspecific binding. Antibodies were as follows: anti-CD8α (clone 
53-6.7), anti-CD4 (GK 1.5), anti-CD44 (Pgp1, Ly-24), anti-CD62L (LECAM-1 
Ly-22), anti-CD45RB (C363-16A), anti-CD25 (3C7), anti CD11b (M1/70), 
anti-CD11c (N418), anti-CD103 (M290), anti-B220 (RA3-6B2) (all from 
BD Biosciences — Pharmingen), and anti–Siglec-H (HM1075F, HyCult Bio-
tech). For intracellular staining, cells were stimulated with PMA/ionomy-
cin, with addition of brefeldin, and then permeabilized with the CytoFix/
CytoPerm kit (BD Biosciences) for intra-cytoplasmic detection of IFN-γ 
(Alexa Fluor 488, clone, XMG1.2, eBioscience), and IL-10 (phycoerythrin, 
clone JES5-16E3, BD Biosciences — Pharmingen). Cells were analyzed with 
a FACScan flow cytometer (BD) equipped with CELLQuest software.
Immunohistochemistry. Snap-frozen OCT-embedded lungs were cryosec-
tioned with a semiautomatic cryostat (MC4000, Histo-Line Laboratories) 
and stained with a combination of Alexa Fluor 488–anti–mouse CD4 
(clone GK1.5, BioLegend) and Alexa Fluor 647–anti–mouse CD8 (clone 
5H10-1, BioLegend) at room temperature for 1 hour. Pictures were taken 
with a fluorescence microscope (BX51, Olympus) using analySIS image 
processing software. DAPI (Molecular Probes, Invitrogen) was used to 
detect nuclei (original magnification, ×20).
Immunofluorescence. Imaging was performed on DCs plated in com-
plete medium into chambered coverglass (Lab-Tek/Nunc; Thermo 
Scientific) in a temperature-regulated environmental chamber. DCs 
were exposed to GFP-conidia (at a 1:4 cell/conidia ratio), Alexa Fluor 
488–Pep1p, and Alexa Fluor 488–Mep1p peptides (1 μg/ml) in serum-
free RPMI-1640 medium and incubated at 37°C for 160 minutes, and 
time chase experiments were done at 5, 15, 45, and 120 minutes. For 
inhibition experiments, cells were preincubated with 5 mM 3-MA or 
5 μg/ml chloroquine for 30 minutes. After washout, cells were fixed in 2% 
formaldehyde for 40 minutes at room temperature and permeabilized in 
a blocking buffer containing 5% FBS, 3% BSA, and 0.5% Triton X-100 in 
PBS. The cells were then incubated at 4°C with primary antibodies pro-
duced in rabbit against mannose receptor (Abcam), Rab5, Rab7, Rab9, 
Rab14, and Lamp1 (Sigma-Aldrich) for 12 hours in a buffer containing 
3% BSA and 0.1% Triton X-100 in PBS. After extensive washing with PBS, 
the cells were incubated at room temperature for 60 minutes with 1:400 
secondary anti-rabbit IgG–TRITC antibody (Sigma-Aldrich). Nuclei 
were counterstained with DAPI. Images were acquired using a fluores-
cence microscope (BX51, Olympus) with a 100× objective and analySIS 
image processing software (Olympus). The co-localization program Fiji 
Figure 8
Distinct pathways of intracellular antigen routing in CD4+ and CD8+ T cell vaccination to Aspergillus fumigatus. The activation of CD4+ and CD8+ 
T cells is contingent upon the nature of the fungal vaccine, the involvement of distinct innate receptor signaling pathways, and the mode of anti-
gen routing and presentation in DCs. Specifically, both soluble fungal antigens and phagocytosed conidia are routed to the endosome/lysosome 
compartment that is apparently required for adequate processing and presentation of antigens for CD4+ T cell activation. At variance with soluble 
antigens, conidia are diverted from the early endosomes to the Rab14+ compartment, required for the alternative MHC class I presentation, 
through autophagy. MHC class I–restricted CD8+, but not MHC class II–restricted CD4+, memory T cells failed to be generated in mice with CGD 
due to defective DC endosomal alkalinization and autophagy, which impeded sorting to the Rab14+ compartment. Note that the non-protective 
fungal antigen Mep1p colocalized rapidly with Rab9 and weakly with Lamp1, a finding suggesting that transporting antigens from late endosome 
to the TGN prevents adequate processing and presentation of antigens for CD4+ T cell activation.
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(http://fiji.sc/wiki/index.php/Fiji) with the JACoP plug-in was used to 
quantify the degree of overlap by calculating the co-localization coeffi-
cients (Pearson’s correlation coefficient, overlap coefficient according to 
Manders, and the overlap coefficients as reported in Supplemental Table 
1). Pep1p and Mep1p were fluorescently labeled using Alexa Fluor 488 
Microscale Protein Labeling Kit (Molecular Probes, Invitrogen) follow-
ing the manufacturer’s instructions. The dye peptide was maintained at 
4°C with the addition of 2 mM sodium azide, protected from light until 
imaging experiments were performed.
Uptake tracking of GFP-expressing A. fumigatus in vivo. To track DC uptake 
of GFP-expressing A. fumigatus in vivo, single-cell suspensions were pre-
pared from lungs depleted of T and B cells, to avoid possible loss of GFP+ 
phagocytes. Cells were immunostained with the CD11c or the CD11b 
markers and analyzed by flow cytometry.
Phagocytosis and conidiocidal assay. GFP-labeled conidia (1 × 106/ml) were 
added to DC monolayers (at a 1:1 ratio) previously adhered to glass cov-
erslips in 24-well tissue culture plates, and phagocytosis was allowed to 
proceed for 2 hours at 37°C. The fluorescence of bound but uningested 
conidia was quenched with trypan blue (0.3 ml of 1 mg/ml in PBS for 15 
minutes at 25°C), and the DCs were fixed in 1% paraformaldehyde. Phago-
cytosis was quantified via phase contrast and fluorescence microscopy at 
×1,000 on a BX51 microscope (Olympus). For determination of fungicidal 
activity, total lung cells were incubated with unopsonized conidia at a 1:1 
ratio at 37°C for 2 hours. Inhibition of colony forming units (expressed 
as mean percentage ± SEM), referred to as conidiocidal activity, was deter-
mined as described previously (22).
In vitro antigen presentation, cytotoxic, and conidiocidal assays. To assess the 
intracellular mechanism of fungal antigen processing, a panel of anti-
gen presentation pathway inhibitors (all from Sigma-Aldrich) at their 
optimum concentrations was added to DCs or macrophages for 120 
minutes prior to the 2-hour pulsing with live conidia or Pep1p. We used 
5 μg/ml chloroquine (an acidophilic weak base that inhibits endosomal 
acidification), 5 μg/ml brefeldin A (to inhibit the vacuolar pathway), 
50 μM lactacystin (to inhibit proteasomal degradation), 5 mM 3-MA 
(to inhibit autophagy), 2 μg/ml DPI (to inhibit ROS generation), and 
50 μM rapamycin (to induce autophagy). After pulsing, DCs were fixed 
in 0.8% paraformaldehyde (Sigma-Aldrich) for 5 minutes and extensively 
washed before use. Treated DCs (1 × 105) were incubated with CD4+ or 
CD8+ T cells (5 × 105), purified from lungs a week after the infection, in 
RPMI-1640 with 10% FCS, 2 mM l-glutamine, and antibiotics, in round-
bottom, 96-well plates for lymphoproliferation (after 72 hours incuba-
tion) or in polypropylene tubes for collection of supernatants and for 
determination of gene expression and cytolytic activity of harvested cells 
(after 24 hours incubation). DNA synthesis was measured by 3H-thymi-
dine labeling (Amersham Biosciences) for 6 hours. Cytolytic activity was 
tested using a standard 4-hour 51Cr release assay. Target cells (conidia-
pulsed DCs) were labeled with 51Cr at 37°C for 45 minutes. A total of 
104 51Cr-labeled targets/well were added to round-bottom, 96-well plates, 
to which effector cells were added in triplicate at the indicated E/T cell 
ratios to a total volume of 200 μl. The plates were incubated for 4 hours 
before 50 μl of supernatant was transferred into sample plates. A total of 
150 μl/well scintillation liquid (OptiPhase SuperMix, PerkinElmer) was 
added, and the sample plates were read on a scintillation gamma coun-
ter. Spontaneous 51Cr-release was measured in control wells containing 
target cells with medium alone. Maximum release values were obtained 
by lysis of target cells with 2.5% Triton X-100 (Sigma-Aldrich). The 
percentage of specific release was calculated as follows: (experimental 
release − spontaneous release)/(maximal release − spontaneous release) 
× 100. A total of 106 live or heat-inactivated conidia of A. fumigatus were 
labeled in the dark with the fluorescent molecular stain FUN-1 (5 μM, 
Molecular Probes) with gentle shaking at 37°C for 30 minutes. After 
washing, FUN-1–stained live conidia were incubated overnight in fresh 
culture medium alone or with 500 μl of culture medium from naive 
CD8+ T cells or cells from infected mice either unexposed or exposed to 
conidia-pulsed DCs and then examined under fluorescence microscopy. 
Because lymphocytes take up FUN-1, cells could not be added directly in 
this assay. Metabolically active conidia accumulate orange fluorescence 
in vacuoles, while dormant and dead conidia stain green.
Cell line cultures, transfection, and autophagy. RAW 264.7 cells (ATCC) 
were seeded in 100-mm petri dish (3.5 × 106) and transfected with the 
EGFP-LC3 plasmid (Addgene) using ExGen 500 in vitro Transfection 
Reagent (Fermentas) for 48 hours, according to the manufacturer’s 
instructions. Transiently transfected RAW 264.7 cells were exposed 
to A. fumigatus resting or swollen conidia (RC or SC, respectively) at 
a cell/fungi ratio of 1:1, 5 μg/ml Pep1p, 50 μM rapamycin (LC Labo-
ratories), or 20 μg/ml poly(I:C) (Sigma-Aldrich) in the presence of 
10 μg/ml pepstatin A and 10 μg/ml E64-D (both from Sigma-Aldrich) 
to inhibit autophagosomal degradation by lysosomal enzymes. Cells 
were incubated for 4 hours (as indicated by preliminary experiments 
performed at 2, 4, or 16 hours) at 37°C in 5% CO2. Cultures growing on 
coverslips were observed at ×100 magnification with the Olympus BX51 
fluorescence microscope using an FITC filter. Results are expressed as 
number of cells with EGFP-LC3 punctae. An equal amount of cell lysate 
in 2× Laemmli buffer (Sigma-Aldrich) was probed with rabbit anti-GFP 
antibody (Abcam) and goat anti-rabbit IgG HRP-conjugated second-
ary antibody (Sigma-Aldrich) after separation in 12% Tris/glycine SDS 
gel and transfer to a nitrocellulose membrane. Normalization was per-
formed by probing the membrane with mouse anti–β-tubulin antibody 
(Sigma-Aldrich) and goat anti-rabbit IgG HRP-conjugated secondary 
antibody (Sigma-Aldrich). Chemiluminescence detection was per-
formed with LiteAblot Plus chemiluminescence substrate (EuroClone), 
using the ChemiDoc XRS+ imaging system (Bio-Rad), and quantifica-
tion was obtained by densitometry image analysis using Image Lab 
3.1.1 software (Bio-Rad). For autophagy on lung cells, 1 × 106 purified 
DCs were stimulated on glass slides in 24 multiwell plates as above and 
incubated for 2 hours at 37°C in 5% CO2. Cells were incubated with 
1:200 diluted anti-LC3 antibody (Cell Signaling Technology) overnight 
at 4°C in PBS containing 3% normal bovine serum albumin, incubated 
with anti-rabbit–PE secondary antibody (Sigma-Aldrich), and fixed 
for 20 minutes in PBS containing 4% paraformaldehyde. Images were 
acquired using the Olympus BX51 fluorescence microscope with a ×40 
objective and analySIS image processing software (Olympus). DAPI was 
used to detect nuclei.
Co-immunoprecipitation assays and Western blot analysis. For co-
immunoprecipitation assays, cells were lysed with the NP-40 lysis buffer 
and incubated with 1:100 diluted rabbit polyclonal antibody to Beclin-1 
(Cell Signaling Technology) overnight at 4°C, with Protein A sepharose 
added (Sigma-Aldrich) for 1 hour at 4°C. Immunoprecipitates were 
subjected to SDS-PAGE gel electrophoresis and probed with polyclonal 
antibody to TRIF (Imgenex) and Beclin-1 followed by anti-rabbit IgG–
peroxidase (Sigma-Aldrich) as secondary antibody. Control experiments 
included Western blotting on immunoprecipitates with an irrelevant anti-
body. For the phospho-ERK detection by Western blot, cells were lysed in 
Laemmli buffer, blotted, and incubated with rabbit polyclonal antibody 
recognizing phospho–p44/p42 ERK (Thr202/Tyr294), followed by HRP–
anti-rabbit IgG, as per the manufacturer’s instruction (Cell Signaling 
Technology). Normalization against β-tubulin was performed by probing 
the membrane with mouse anti–β-tubulin antibody and goat anti-rabbit 
IgG HRP-conjugated secondary antibody (Sigma-Aldrich). Chemilumi-
nescence detection was performed as above.
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siRNA design. The siRNA sequences specific for mouse Becn1 (sense, 
5′-CUGAGAAUGAAUGUCAGAAdTdT-3′; antisense, 5′-UUCUGACAUU-
CAUUCUCAGdTdT-3′) were selected, synthesized, and annealed by the 
manufacturer and were used in combination with scrambled control 
siRNA (Sigma-Aldrich).
ELISA and real-time PCR. The level of cytokines in culture supernatants 
was determined by ELISA Kit (R&D Systems). The detection limits of 
the assays were less than 10 pg/ml for IL-12p70, less than 3 pg/ml for 
IL-10, less than 30 pg/ml for IL-23, and less than 10 pg/ml for IL-17A. 
Real-time RT-PCR was performed using the iCycler iQ Detection Sys-
tem (Bio-Rad) and SYBR Green chemistry (Finnzymes Oy). Cells were 
lysed, and total RNA was extracted using RNeasy Mini Kit (QIAGEN) 
and was reverse transcribed with Sensiscript Reverse Transcriptase 
(QIAGEN) according to the manufacturer’s directions. PCR primers 
for cytokines were as described previously (22). The following primers 
were used: Atg12 sense, 5′-AATCATGCAGGGACACAGTT-3′, antisense, 
5′-CACTCTTCCTGCTCAGGTGT-3′; Bcn1 sense, 5′-CAATCTCAAGT-
GGGGTCTT-3′, antisense, 5′-GGCAAACATCCCCTAAGG-3′; LC3a 
sense, 5′-AGCTTCGCCGACCGCTGTAAG-3′, antisense, 5′-CTTCTCCT-
GTTCATAGATGTCAGC-3 ′ ;  LC3b sense, 5′-CGGAGCTTTGAA-
CAAAGAGTG-3′, antisense, 5′-TCTCTCACTCTCGTACACTTC-3′. 
Amplification efficiencies were validated and normalized against Gapdh. 
The thermal profile for SYBR Green real-time PCR was 95°C for 3 min-
utes, followed by 40 cycles of denaturation for 30 seconds at 95°C and 
an annealing/extension step of 30 seconds at 60°C. Each data point 
was examined for integrity by analysis of the amplification plot. The 
mRNA-normalized data were expressed as relative cytokine mRNA in 
treated cells compared with that in unstimulated cells.
Statistics. For multiple comparisons, P values were calculated by using 
1-way ANOVA (Bonferroni post hoc test), as specified for individual 
P values described in figure legends. For single comparisons, P values were 
calculated by using 2-tailed Student’s t test. The data reported are either 
from one representative experiment of 3–5 independent experiments or 
were compiled from 3–5 experiments. At least 6 mice per group per experi-
ment were used, as computed by power analysis to yield a power of at least 
80% with an α value of 0.05.
Study approval. Experiments were performed according to Italian 
Approved Animal Welfare Assurance A–3143–01, and protocols licensed 
by the Italian Ministry of Health. Infections were performed under avertin 
anesthesia, and all efforts were made to minimize suffering.
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